August 26, 2021 Just as clunky cathode ray tube televisions were displaced in the 1980s by flat panel, vivid displays, today’s audio technology may soon be displaced by graphene-based audio tech. In 2014, principal investigator Alex Zettl and postdoctoral researcher Qin Zhou of Berkeley Lab and the University of California at Berkeley published a seminal paper about … [Read more...] about Graphene-Based Material Takes Audio Tech to the Next Level
Success Stories
Infant-Warming Device Proven Safe and Effective
A recent study found that an infant-warming device developed at Berkeley Lab and UC Berkeley is safe and effective at lowering newborn mortality rates associated with hypothermia. The device contains phase-change material, which can absorb and release large amounts of thermal energy or heat. Read about the study here. … [Read more...] about Infant-Warming Device Proven Safe and Effective
Newomics Closes $7.9 Million Series B Financing to Accelerate Growth (Newomics Announcement)
Berkeley Lab startup Newomics, founded on the multinozzle emitter array (MEA) technology invented at Berkeley Lab, continues to grow. According to the announcement: Daojing Wang, Ph.D., Newomics' founder and CEO, says the proceeds will be used to launch new products, grow the sales and marketing team, enhance customer support, and expand the collaborations with prominent mass … [Read more...] about Newomics Closes $7.9 Million Series B Financing to Accelerate Growth (Newomics Announcement)
Success Story: Next-generation Boron Nitride Nanotubes
Invention: Boron Nitride Nanotube Licensee: EPIC Advanced Materials The boron nitride nanotube (BNNT) is a breakthrough material for energy, aerospace, electronics, and medicine applications. Invented by Lawrence Berkeley National Laboratory (LBNL), the technology allows quality scale up of a material that is 100 times stronger than steel, heat resistant to 900°C, … [Read more...] about Success Story: Next-generation Boron Nitride Nanotubes
CinderBio Receives Funding to Commercialize Proteomics Enzymes
On April 2, the National Institutes of Health awarded CinderBio a $1.6M Phase II SBIR to commercialize its proteomics enzymes over the next two years. Proteomics is the broad study of proteins that is transitioning from R&D applications to more applied fields such as clinical applications and diagnostics. The mass-spectrometry based proteomics market is projected to be … [Read more...] about CinderBio Receives Funding to Commercialize Proteomics Enzymes